Compound Detail
CHEMBL4867199
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CS(=O)(=O)[O-].Cn1cc([C+](c2ccc(C(F)(F)F)cc2)c2c[nH]c3ccccc23)c2ccccc21
Basic Information
| ChEMBL ID | CHEMBL4867199 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PXFDXVREKLYKIR-UHFFFAOYSA-M |
| Parent Compound | CHEMBL5028857 |
| Active Moiety | CHEMBL5028857 |
7
Targets
8
Activities
2
Assay Types
11
PK Parameters
11
Publications
0
Known Names
Molecular Properties
403.4
MW (Da)
6.70
ALogP
1
HBA
1
HBD
20.7
PSA (Ų)
0.32
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 7.4
Kd 2 meas. best 7.48
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nuclear receptor subfamily 4immunitygroup A member 1 CHEMBL1293229 | Kd | 7.48 | 7.33 | 33.0 | 2 |
| BT-549 CHEMBL614072 | IC50 | 7.4 | 7.4 | 40.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 7.22 | 7.22 | 60.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 7.05 | 7.05 | 90.0 | 1 |
| SW-620 CHEMBL612262 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| MCF-10A CHEMBL614321 | IC50 | 5.66 | 5.66 | 2190.0 | 1 |
| NCM460 CHEMBL4483264 | IC50 | 5.33 | 5.33 | 4630.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 501.35 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 733.56 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 17.0 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 1390.08 | nM | Rattus norvegicus |
| Cmax | 143.59 | nM | Rattus norvegicus |
| F | 14.63 | % | Rattus norvegicus |
| MRT | 0.56 | hr | Rattus norvegicus |
| MRT | 9.59 | hr | Rattus norvegicus |
| T1/2 | 2.66 | hr | Rattus norvegicus |
| T1/2 | 4.49 | hr | Rattus norvegicus |
| Tmax | 3.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33279290 | 10.1016/j.ejmech.2020.113020 | ADMET | 15 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | Nuclear receptor subfamily 4immunitygroup A member 1 | 7 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | MDA-MB-231 | 7 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | HCT-116 | 7 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | BT-549 | 6 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | SW-620 | 6 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | MEF | 3 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | Unchecked | 2 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | MCF-10A | 1 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | NCM460 | 1 |
| 33279290 | 10.1016/j.ejmech.2020.113020 | Mus musculus | 1 |
Data from ChEMBL 36 via Core Engine